Related Experiment Video

Updated: Aug 24, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

Sir Howard Walter Florey--the force behind the development of penicillin

B Lee Ligon1

  • 1Department of Pediatrics, Baylor College of Medicine, 66212 Fannin, A-150, Houston, TX 77030, USA. bligon@bcm.tmc.edu

Seminars in Pediatric Infectious Diseases
|June 9, 2004
PubMed

Insights

Sir Alexander Fleming discovered penicillin, but Sir Howard Florey and Ernst Chain developed it for medical use. Their work revolutionized infectious disease treatment and earned them a Nobel Prize.

Area of Science:

  • Medical History
  • Bacteriology
  • Pharmacology

Background:

  • Penicillin's discovery by Alexander Fleming was serendipitous, occurring in 1928.
  • Fleming's initial discovery received little attention for over a decade.
  • The isolation and mass production of penicillin remained elusive for many years.

Discussion:

  • Sir Howard Florey and Ernst Chain led a British scientific team in 1939.
  • They successfully isolated and manufactured penicillin from its growth medium.
  • This breakthrough enabled the widespread use of penicillin as an antibiotic.

Key Insights:

  • The collaborative efforts of Fleming, Florey, and Chain were crucial for penicillin's development.
  • Florey and Chain's work transformed Fleming's discovery into a life-saving drug.
  • Penicillin's development marked a significant advancement in combating bacterial infections.

Outlook:

  • The development of penicillin ushered in the age of antibiotics.
  • It dramatically reduced mortality rates from infectious diseases.
  • Further research continues to build upon the foundation laid by penicillin's discovery and development.

More Related Videos

Stress-induced Antibiotic Susceptibility Testing on a Chip12:41

Stress-induced Antibiotic Susceptibility Testing on a Chip

Published on: January 8, 2014

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa11:31

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa

Published on: June 30, 2016

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
History of Microbiology01:28

History of Microbiology

Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.